Titan PharmaceuticalsTTNP
13F holders, Q1 2024 (March 31)17holders
$7.16avg. 13F price*
At the end of Q1 2024, 17 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings. The largest holders were Truist Financial Corp. ($224K), Tower Research Capital LLC (TRC) ($5K) and MCF Advisors LLC ($1K).
- Company
- Titan Pharmaceuticals Inc.
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $1K |
| Exits | 0 | $0 |
Ownership 17 holders
| Truist Financial Corp. | 0.00% | Reduce -80.0% | 31,255 | $224K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +67.6% | 647 | $5K |
| MCF Advisors LLC | 0.00% | New | 165 | $1K |
| Bank of America Corp. | 0.00% | Reduce -76.8% | 12 | $86 |
| Group One Trading LLC | 0.00% | Reduce -79.1% | 12 | $86 |
| Osaic Holdings, Inc. | 0.00% | Add +8.1% | 10 | $70 |
| Wells Fargo & Company | 0.00% | Reduce -77.5% | 5 | $36 |
| Morgan Stanley | 0.00% | Add +300.0% | 3 | $21 |
| Global Wealth Strategies & Associates | 0.00% | Reduce -80.0% | 2 | $14 |
| Nemes Rush Group LLC | 0.00% | New | 1 | $8 |
| Caldwell Sutter Capital, Inc. | 0.00% | Reduce -50.0% | 1 | $7 |
| St Germain D J Co. Inc. | 0.00% | Add +300.0% | 1 | $7 |
| Westside Investment Management, Inc. | 0.00% | No change | 1 | $7 |
| UBS Group AG | 0.00% | Add +100.0% | 1 | $7 |
| NewEdge Advisors, LLC | 0.00% | No change | 1 | $7 |
| Cape Investment Advisory, Inc. | 0.00% | New | 1 | $7 |
| Ransom Advisory, Ltd | 0.00% | — | 1 | $7 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.